Literature DB >> 32980074

Identifying End Users' Preferences about Structuring Pharmacogenetic Test Orders in an Electronic Health Record System.

Leland E Hull1, Jason L Vassy2, Annjanette Stone3, Catherine C Chanfreau-Coffinier4, Craig W Heise5, Victoria M Pratt6, Ronald Przygodzki7, Corrine I Voils8, Deepak Voora9, Jessica Wang-Rodriguez10, Steven A Schichman3, Maren T Scheuner11.   

Abstract

Pharmacogenetics (PGx) testing can be used for detecting genetic variations that may affect an individual's anticipated metabolism of, or response to, medications. Although several studies have focused on developing tools for delivering results from PGx testing, there is a relative dearth of information about how to design provider-friendly electronic order-entry systems for PGx. The U.S. Department of Veterans Affairs (VA) is preparing to implement a new electronic health records system. In this study, VA PGx test end users were surveyed about their preferences for how electronic test orders for PGx should be structured, including the nomenclature that should be used to search for and identify PGx-test orders, whether to offer single- versus multigene tests, and whether information about test methodology should be included in the order name. Responses were analyzed systematically to identify areas of agreement and disagreement with the survey options, and areas where respondents' opinions diverged. End users endorsed preferences for flexible ways to identify and order PGx tests and multigene panel tests; opinions on whether test methodology should be included in the test name were divergent. The results could be used for both informing the VA's new electronic health records implementation (including how PGx tests are searched for and ordered) and for providing insights for other health systems implementing PGx-testing programs.
Copyright © 2020 Association for Molecular Pathology and American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Year:  2020        PMID: 32980074      PMCID: PMC7527867          DOI: 10.1016/j.jmoldx.2020.06.015

Source DB:  PubMed          Journal:  J Mol Diagn        ISSN: 1525-1578            Impact factor:   5.568


  18 in total

1.  Computer physician order entry: benefits, costs, and issues.

Authors:  Gilad J Kuperman; Richard F Gibson
Journal:  Ann Intern Med       Date:  2003-07-01       Impact factor: 25.391

2.  Adoption of pharmacogenomic testing by US physicians: results of a nationwide survey.

Authors:  E J Stanek; C L Sanders; K A Johansen Taber; M Khalid; A Patel; R R Verbrugge; B C Agatep; R E Aubert; R S Epstein; F W Frueh
Journal:  Clin Pharmacol Ther       Date:  2012-01-25       Impact factor: 6.875

3.  Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.

Authors:  Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde
Journal:  J Biomed Inform       Date:  2008-09-30       Impact factor: 6.317

4.  FDA oversight of laboratory-developed tests will facilitate adoption of pharmacogenetic testing into routine clinical care.

Authors:  E Hillebrenner; E Litwack; P Bradley; K Donigan; T Lowe; K Serrano; K Kelm; E Mansfield; A Gutierrez
Journal:  J Clin Pharmacol       Date:  2015-07       Impact factor: 3.126

5.  VA Primary Care and Mental Health Providers' Comfort with Genetic Testing: Survey Results from the PRIME Care Study.

Authors:  Leland E Hull; Kevin G Lynch; David W Oslin
Journal:  J Gen Intern Med       Date:  2019-06       Impact factor: 5.128

Review 6.  Preemptive Panel-Based Pharmacogenetic Testing: The Time is Now.

Authors:  Kristin W Weitzel; Larisa H Cavallari; Lawrence J Lesko
Journal:  Pharm Res       Date:  2017-05-02       Impact factor: 4.200

Review 7.  Integrating pharmacogenomics into electronic health records with clinical decision support.

Authors:  J Kevin Hicks; Henry M Dunnenberger; Karl F Gumpper; Cyrine E Haidar; James M Hoffman
Journal:  Am J Health Syst Pharm       Date:  2016-12-01       Impact factor: 2.637

8.  Primary care physicians' knowledge of and experience with pharmacogenetic testing.

Authors:  S B Haga; W Burke; G S Ginsburg; R Mills; R Agans
Journal:  Clin Genet       Date:  2012-07-03       Impact factor: 4.438

9.  Pharmacogenetic testing in the Veterans Health Administration (VHA): policy recommendations from the VHA Clinical Pharmacogenetics Subcommittee.

Authors:  Jason L Vassy; Annjanette Stone; John T Callaghan; Margaret Mendes; Laurence J Meyer; Victoria M Pratt; Ronald M Przygodzki; Maren T Scheuner; Jessica Wang-Rodriguez; Steven A Schichman
Journal:  Genet Med       Date:  2018-06-01       Impact factor: 8.822

Review 10.  Understanding and preventing drug-drug and drug-gene interactions.

Authors:  Cara Tannenbaum; Nancy L Sheehan
Journal:  Expert Rev Clin Pharmacol       Date:  2014-04-19       Impact factor: 5.045

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.